Generics 247

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ampicillin manufacturers

247 products found

Filters

247 products found

ampicillin + sulbactam

Injection 1.5 g, 3 g, 15 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA
Unavailable markets
Vietnam
Registered in
United States
Available for
Distribution only
MAs for sale
United States
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 11 days

ampicillin

Capsules 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21631

Manufacturer usually replies in 5 days

ampicillin

Vials, injection 0.25 g, 0.5 g, 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark , Finland , Norway , Sweden , Vietnam
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

ampicillin

Solution for injection 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

ampicillin

Solution for injection 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

ampicillin

Powder for solution for injection/infusion 500 mg, 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark , Finland , Iceland , Netherlands , Norway , Sweden
Available for
Licensing with supply, Distribution only
Comments
RLD-Doktacillin (Meda)
Manufacturer #19992
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products for 190+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main therapy areas include anti-infectives, dermatology, and CNS. The company products are prepared in CTD dossier format.

Manufacturer usually replies in 6 days

ampicillin

Solution for injection 500 mg/vial, 1 g/vial, 2 g/vial, 10 g/vial

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
Vietnam , United States
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

ampicillin + cloxacillin

Capsules 250 mg + 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #16196
The company is committed to providing and addressing healthcare needs as well as delivering patient care services across the globe. Through state of art facility, they have been working for more than 60 years and delivering nothing short of excellent.

Manufacturer usually replies in 10 days

ampicillin + cloxacillin

Oral suspension 125 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #16196
The company is committed to providing and addressing healthcare needs as well as delivering patient care services across the globe. Through state of art facility, they have been working for more than 60 years and delivering nothing short of excellent.

Manufacturer usually replies in 10 days

ampicillin + sulbactam

Solution for injection 1,5g 3g 15g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

ampicillin + sulbactam

Powder for solution for injection 1 g + 0.5 g, 2 g + 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #298

Manufacturer usually replies in 5 days

ampicillin + sulbactam

Vials, injection 750mg, 1,5g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

ampicillin

Powder for suspension for injection 250 mg, 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Balkans only
Manufacturer #15070
A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

ampicillin + sulbactam

Powder for solution for infusion 500 mg + 250 mg, 1 g + 500 mg, 2 g + 1 g

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
RLD-Unasyn Dossier availability date: Q1 2024
Manufacturer #19992
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products for 190+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main therapy areas include anti-infectives, dermatology, and CNS. The company products are prepared in CTD dossier format.

Manufacturer usually replies in 6 days

ampicillin

Vials, injection 500 mg, 1 g, 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

ampicillin

Capsules 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #13689
A pharmaceutical manufacturer based in the EU that has been active in Europe and MENA for 20+ years. The main therapeutic areas include cardiovascular, respiratory, and ophthalmology. The company's production lines are GMP-compliant. Key production lines are Rx, OTC, and nutraceuticals. The main dosage forms include oral solid dosage forms.

Manufacturer usually replies in 10 days

ampicillin

Injection 250 mg , 500 mg , 1 g , 2 g , 10 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark , Finland , Ireland , Norway , Sweden
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 11 days

ampicillin + sulbactam

Powder for solution for injection/infusion 1000 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Czech Republic , Serbia , Slovakia , Vietnam
Comments
Reference medicine: Unasyn, Pfizer
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 20 days

ampicillin

Vials, injection 250 mg, 500 mg, 1000 mg, 2000mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Reference product: Doktacillin, Meda AB
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 20 days

ampicillin

Powder for solution for injection/infusion 250 mg,

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Reference product: Ampicillin for injection USP Sandoz
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 20 days

Want to view all 247 products? Create your free account today!

Ampicillin

Ampicillin is an antibiotic that can be used to treat many bacterial infections such as meningitis and salmonellosis. It can also be used to prevent group A streptococcal infections in newborns. It was the principal "expansive range" penicillin with action against Gram-positive microorganisms, including Streptococcus pneumoniae, Streptococcus pyogenes, some disengages of Staphylococcus aureus (yet not penicillin-safe or methicillin-safe strains), Trueperella, and some Enterococcus. It can also be used to combat multiple drug-resistant Enterococcus foecalis and E. faecium.

How does Ampicillin work?

It acts by inhibiting the bacterial cell wall synthesis through binding one or more penicillin binding proteins. It also has a bacterial-autolytic effect through inhibition of certain penicillin binding proteins (PBPs) that are involved in activating a bacterial self-destructive process. Ampicillin, like other antibiotics, will not be effective against colds, flus, or other viral infections. You run the risk of developing an infection that resists antibiotic treatment if you take antibiotics when you don't need them. Co-administration with sulbactam increases its activity spectrum. This drug inhibits beta lactamase which is an enzyme that bacteria produces to inactivate antibiotics. Sometimes, it is used with other antibiotics, such as vancomycin and linezolid. Hypersensitivity to penicillins can make it unsafe to use ampicillin. Hypersensitivity reactions may include skin rashes, erythema multiforme and temporary decreases in red and white blood cell count. It is a common drug used in pregnancy. It has been classified as a category B by the Food and Drug Administration (U.S.) and A by the Therapeutic Goods Administration (Australia). It is the preferred drug for Listeria monocytogenes treatment in pregnant women. It can be used alone or with an aminoglycoside. It was first discovered in 1958. It became commercially available in 1961. It is listed on the Essential Medicines list. It is a critical medicine for humans according to the World Health Organization. It can be purchased as a generic drug.

Pricing of Ampicillin

The cost for this medicine injectable powder for injection 2 g is around $29 for a supply of 10 powder for injection. it's major manufactures include Principen, Omnipen-N, Totacillin-N, etc.

Sourcing Ampicillin Manufacturers and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Ampicillin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturers and this substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Ampicillin . Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Ampicillin Sodium is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ampicillin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Ampicillin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.